These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 8855226
1. Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling. Rühmann A, Köpke AK, Dautzenberg FM, Spiess J. Proc Natl Acad Sci U S A; 1996 Oct 01; 93(20):10609-13. PubMed ID: 8855226 [Abstract] [Full Text] [Related]
2. Novel high-affinity photoactivatable antagonists of corticotropin-releasing factor (CRF) photoaffinity labeling studies on CRF receptor, type 1 (CRFR1). Bonk I, Rühmann A. Eur J Biochem; 2000 May 01; 267(10):3017-24. PubMed ID: 10806401 [Abstract] [Full Text] [Related]
3. Development of a selective photoactivatable antagonist for corticotropin-releasing factor receptor, type 2 (CRF2). Bonk I, Rühmann A. Eur J Biochem; 2002 Nov 01; 269(21):5288-94. PubMed ID: 12392562 [Abstract] [Full Text] [Related]
4. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant. Myers DA, Trinh JV, Myers TR. Mol Cell Endocrinol; 1998 Sep 25; 144(1-2):21-35. PubMed ID: 9863624 [Abstract] [Full Text] [Related]
5. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. Rühmann A, Bonk I, Lin CR, Rosenfeld MG, Spiess J. Proc Natl Acad Sci U S A; 1998 Dec 22; 95(26):15264-9. PubMed ID: 9860957 [Abstract] [Full Text] [Related]
6. High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1. Rühmann A, Bonk I, Köpke AK. Peptides; 1999 Nov 22; 20(11):1311-9. PubMed ID: 10612445 [Abstract] [Full Text] [Related]
7. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex. Grigoriadis DE, Zaczek R, Pearsall DM, De Souza EB. Endocrinology; 1989 Dec 22; 125(6):3068-77. PubMed ID: 2555137 [Abstract] [Full Text] [Related]
8. The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies. Grigoriadis DE, De Souza EB. J Biol Chem; 1988 Aug 05; 263(22):10927-31. PubMed ID: 2839512 [Abstract] [Full Text] [Related]
9. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB. Mol Pharmacol; 1996 Sep 05; 50(3):679-86. PubMed ID: 8794910 [Abstract] [Full Text] [Related]
10. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data. Dieterich KD, Grigoriadis DE, De Souza EB. Endocrinology; 1994 Oct 05; 135(4):1551-8. PubMed ID: 7925116 [Abstract] [Full Text] [Related]
11. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists. Eckart K, Jahn O, Radulovic J, Tezval H, van Werven L, Spiess J. Proc Natl Acad Sci U S A; 2001 Sep 25; 98(20):11142-7. PubMed ID: 11572971 [Abstract] [Full Text] [Related]
12. The role of the fourth extracellular domain of the rat corticotropin-releasing factor receptor type 1 in ligand binding. Sydow S, Flaccus A, Fischer A, Spiess J. Eur J Biochem; 1999 Jan 25; 259(1-2):55-62. PubMed ID: 9914475 [Abstract] [Full Text] [Related]
13. Characterization of a sheep brain corticotropin releasing factor binding protein. Behan DP, Cepoi D, Fischer WH, Park M, Sutton S, Lowry PJ, Vale WW. Brain Res; 1996 Feb 19; 709(2):265-74. PubMed ID: 8833763 [Abstract] [Full Text] [Related]
14. Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization. Grigoriadis DE, De Souza EB. Peptides; 1989 Feb 19; 10(1):179-88. PubMed ID: 2546128 [Abstract] [Full Text] [Related]
15. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Tezval H, Jahn O, Todorovic C, Sasse A, Eckart K, Spiess J. Proc Natl Acad Sci U S A; 2004 Jun 22; 101(25):9468-73. PubMed ID: 15192151 [Abstract] [Full Text] [Related]
16. Structure-function relationship of different domains of the rat corticotropin-releasing factor receptor. Sydow S, Radulovic J, Dautzenberg FM, Spiess J. Brain Res Mol Brain Res; 1997 Dec 15; 52(2):182-93. PubMed ID: 9495539 [Abstract] [Full Text] [Related]
17. Homologous desensitization of human corticotropin-releasing factor1 receptor in stable transfected mouse fibroblast cells. Dieterich KD, Grigoriadis DE, De Souza EB. Brain Res; 1996 Feb 26; 710(1-2):287-92. PubMed ID: 8963673 [Abstract] [Full Text] [Related]
18. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile. Dautzenberg FM, Kilpatrick GJ, Wille S, Hauger RL. J Neurochem; 1999 Aug 26; 73(2):821-9. PubMed ID: 10428081 [Abstract] [Full Text] [Related]
19. Characterization of corticotropin-releasing factor receptors in dissociated brain cell cultures. Kapcala LP, De Souza EB. Brain Res; 1988 Jul 19; 456(1):159-67. PubMed ID: 2842000 [Abstract] [Full Text] [Related]